Effect of Strengthening the Hip Abductor in Patients With Knee Osteoarthritis: Randomized Controlled Trial
1 other identifier
interventional
66
1 country
1
Brief Summary
Osteoarthritis (OA) is a prevalent disease associated with significant morbidity and is one of the most common causes of joint pain. Characterized by their chronicity, slow and progressive evolution. The overall prevalence of symptomatic knee osteoarthritis is estimated at 3.8%, with peak prevalence in the population with an average age of 50 years. The main objectives of interventions in patients with knee OA are reduced pain and improved functional capacity and exercises are widely recommended. The literature shows a lack of clinical trials verifying the effect of strengthening the hip muscles in patients with knee osteoarthritis. Thus, the aim of this study is to assess the effect of strengthening the hip abductor muscles versus hip adductor muscles in patients with symptomatic OA of the knee.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 5, 2016
CompletedFirst Posted
Study publicly available on registry
September 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2018
CompletedNovember 2, 2018
October 1, 2018
1.7 years
September 5, 2016
October 31, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Numeric Pain Scale
Pain was assessed by use of an 11-point Numeric Pain Scale, where 0 corresponded to no pain and 10 corresponded to worst imaginable pain.
Six weeks
Pain and Function subscale - Knee Injury and Osteoarthritis Outcome Score
Pain and Function subscale - KOOS was assessed, where 0 corresponded to no pain and normal function and 100 corresponded to worst pain and function.
Six weeks
Secondary Outcomes (7)
Others subscales - Knee Injury and Osteoarthritis Outcome Score
Six weeks
30 s Chair Stand Test
Six weeks
Timed Up & Go Test
Six weeks
Global Perceived Effect Scale
Six weeks
Numeric Pain Scale
Six months
- +2 more secondary outcomes
Study Arms (2)
Group Hip Abductor Exercise
EXPERIMENTAL12 treatments sessions at 6 weeks: Heating, lower limb stretching, tibiofemoral and patellofemoral mobilization, strengthening the quadriceps, hamstrings, triceps sural and hip abductors.
Group Hip Aductor Exercise
ACTIVE COMPARATOR12 treatments sessions at 6 weeks: Heating, lower limb stretching, tibiofemoral and patellofemoral mobilization, strengthening the quadriceps, hamstrings, triceps sural and hip aductors.
Interventions
12 treatments sessions at 6 weeks: Heating, lower limb stretching, tibiofemoral and patellofemoral mobilization, strengthening the quadriceps, hamstrings, triceps sural and hip abductors.
12 treatments sessions at 6 weeks: Heating, lower limb stretching, tibiofemoral and patellofemoral mobilization, strengthening the quadriceps, hamstrings, triceps sural and hip aductors.
Eligibility Criteria
You may qualify if:
- OA knee radiograph grades 2 - 4 according to the Kellgren-Lawrence scale;
- Reporting knee pain with minimum intensity of 3 on Numerical Pain Scale;
- Complaints of pain and functional reduction in the last three months;
- Meet at least one of the American College of Rheumatology classification criteria;
- Deambulation independent;
- Absence of prostheses or orthoses
- Predominant pain in the medial aspect of the knee.
You may not qualify if:
- Contraindications for physical exercises evaluated by the Physical Activity Readiness Questionnaire (PAR-Q);
- Diabetes type I or decompensated;
- Hypertension decompensated;
- Cardiac pacemaker;
- Cancer History
- Neurological deficits (sensory or motor)
- Body mass index above 40 kg / m2
- Hip symptomatic osteoarthriti
- Orthopedic surgery of the lower limbs
- Systemic inflammatory disease
- Can not walk.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal University of Ceara
Fortaleza, Ceará, 60430-160, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gabriel Peixoto Leão Almeida, PhD student
Federal University of Ceará (UFC), Brazil.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 5, 2016
First Posted
September 15, 2016
Study Start
September 1, 2016
Primary Completion
May 1, 2018
Study Completion
November 1, 2018
Last Updated
November 2, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared.